The nasal spray is now undergoing phase three trials ... Scientists in the UK are also studying ketamine as a treatment for depression taken intravenously. Dr James Stone, from the Royal College ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... to treat depression. Ketamine has long been seen as a potential breakthrough in depression treatment, despite safety ...

Meanwhile, the nasal spray form of ketamine, called esketamine and sold ... And how do the two compare head to head in actual response to treatment? That's what researchers at Yale University ...

The nasal spray version, esketamine ... He notes, however, that “ketamine isn’t a first-option treatment for depression.” “It ...

Ketamine treatment is not something that's new ... But back inJuly, Johnson and Johnson did seek approval for a nasal Ketamine spray, that is currently in waiting.

According to an article in the June 2022 issue of Psychiatry Research, "Replicated clinical trials have demonstrated rapid and robust antidepressant effects with ketamine in treatment-resistant ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...